Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML.
Short NJ, Rafei H, Daver N, Hwang H, Ning J, Jorgensen JL, Kadia TM, DiNardo CD, Wang SA, Jabbour E, Popat U, Oran B, Cortes J, Konopleva M, Yilmaz M, Issa GC, Kantarjian H, Ravandi F.
Short NJ, et al. Among authors: konopleva m.
Blood Adv. 2020 Dec 22;4(24):6117-6126. doi: 10.1182/bloodadvances.2020002811.
Blood Adv. 2020.
PMID: 33351107
Free PMC article.